Revvity Inc. RVTY
151.11
0.43
0.29%
as of 25 Sep
- Market cap
- $16.8B
- P/E
- 72.0×
Follow RVTY
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Revvity Inc. (RVTY) Book value per share
Revvity Inc.'s book value per share at the end of fiscal 2025 was 62.2×, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was 64.8×. Over the past ten years it has ranged from 18.8× (fiscal 2015) to 63.1× (fiscal 2023); the current reading is higher than 82% of that period. Revvity Inc. ranks 7th of 52 Diagnostics & Research companies by book value per share.
Book value per share, annual
Annual
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 62.2× | (0.39%) |
| FY2024 | 62.5× | (1.07%) |
| FY2023 | 63.1× | 7.88% |
| FY2022 | 58.5× | (4.80%) |
| FY2021 | 61.5× | 83.52% |
| FY2020 | 33.5× | 31.94% |
| FY2019 | 25.4× | 8.59% |
| FY2018 | 23.4× | 2.61% |
| FY2017 | 22.8× | 15.83% |
| FY2016 | 19.7× | 4.87% |
Quarterly
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 64.8× | 0.88% |
| Mar 2026 | 64.2× | 3.22% |
| Dec 2025 | 62.2× | (2.66%) |
| Sep 2025 | 63.9× | (0.61%) |
| 42 more quarters | Free account |
Against its own ten years
Low 18.8×
High 63.1×
Ten-year median
33.5×
Current reading's percentile
82
Book value per share against peers
| Company | Book value per share |
|---|---|
| ICLR ICON PLC compare | 122× |
| LH Labcorp Holdings Inc. compare | 105× |
| DGX Quest Diagnostics Incorporated compare | 70.4× |
| RVTY Revvity Inc. | 64.8× |
| CRL Charles River Laboratories International, Inc. compare | 59.3× |
| MEDP Medpace Holdings, Inc. compare | 15.4× |
| TWST Twist Bioscience Corporation compare | 7.1× |
| MTD Mettler-Toledo International, Inc. compare | 0.6× |
| GH Guardant Health, Inc. compare | −1.7× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on RVTY
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- The full statement